A similar protective effect of the A2AR antagonist SCH58261 was also observed in AD transgenic (3xTgAD and APP/PS1) mouse models (Viana da Silva et al., 2016; Silva et al., 2018). The gene discussed is APP; the disease is Alzheimer disease.